Patent US6881199B2 successfully refreshed from Google Patents.
← Back to Patent Explorer
US6881199B2 Expired / Lapsed US ⏱️ 0.0 years remaining

Left ventricular conduit with blood vessel graft

Assignee: Jvt Research & Development Corp
•
Filing: 2001-04-10
•
Granted: 2005-04-19
•
Expires: 2021-04-10
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract A method of flowing blood from a heart chamber to a coronary vessel includes providing a conduit with a first end and second end, providing the conduit within a heart wall such that the first end of the conduit is open towards the heart chamber and the second end is open towards the blood vessel, and during diastole, restricting a flow of blood from the coronary vessel to the heart chamber via the natural valve.

Inventors

  • 👤 Peter J. Wilk
  • 👤 David Y. Phelps
  • 👤 Scott J. Wolf

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-23 08:22
CPC Classifications
A; A61; A61F; A61F2/00; A61F2/82; A61F2/02; A61F2/24; A61F2/2493; A61F2/848; A61F2/86; A61F2/90; A61F2/91; A61F2/94; A61M; A61M27/00; A61M27/002; A61F2/95; A61F2/958; A61F2/962; A61M2210/00; A61M2210/12; A61M2210/125

Claims Analysis

Total Claims: 21
Claim 1
Independent Claim 82 words
A method of flowing blood from a heart chamber to a coronary vessel, the method comprising: providing a conduit with a first end and a second end; providing a natural valve; placing the conduit within a heart wall such that the first end of the conduit is open towards the heart chamber and the second end is open towards the blood vessel; and during diastole, restricting a flow of blood from the coronary vessel to the heart chamber via the natural valve.
Claim 2
Independent Claim 82 words
A method of flowing blood from a heart chamber to a coronary vessel, the method comprising: providing a conduit with a first end and a second end; providing a natural valve; placing the conduit within a heart wall such that the first end of the conduit is open towards the heart chamber and the second end is open towards the blood vessel; and during diastole, restricting a flow of blood from the coronary vessel to the heart chamber via the natural valve.
Claim 3
Dependent Claim 25 words
The method of claim 1 , wherein providing the natural valve includes providing a section of blood vessel containing at least one naturally occurring valve.
Claim 4
Dependent Claim 16 words
The method of claim 2 , wherein the section of blood vessel is a human vein.
Claim 5
Dependent Claim 15 words
The method of claim 2 , wherein the section of blood vessel is an autograft.
Claim 6
Dependent Claim 15 words
The method of claim 2 , wherein the section of blood vessel is an allograft.
Claim 7
Dependent Claim 15 words
The method of claim 2 , wherein the section of blood vessel is a xenograft.
Claim 8
Dependent Claim 19 words
The method of claim 1 , wherein providing the natural valve includes providing the natural valve inside the conduit.
Claim 9
Dependent Claim 14 words
The method of claim 1 , wherein the heart chamber is a left ventricle.
Claim 10
Dependent Claim 14 words
The method of claim 1 , wherein the coronary vessel is a coronary artery.
Claim 11
Dependent Claim 93 words
A bypass system for implantation in a body of a patient, the system comprising: a tube having a first end and a second end and being configured to be implanted in a heart wall such that the first end is open towards a heart chamber and the second end is open towards a coronary vessel, the tube being further configured to permit blood to flow therethrough from the heart chamber to the coronary vessel; and a natural valve configured to restrict blood flow from the coronary vessel to the heart chamber during diastole.
Claim 12
Dependent Claim 93 words
A bypass system for implantation in a body of a patient, the system comprising: a tube having a first end and a second end and being configured to be implanted in a heart wall such that the first end is open towards a heart chamber and the second end is open towards a coronary vessel, the tube being further configured to permit blood to flow therethrough from the heart chamber to the coronary vessel; and a natural valve configured to restrict blood flow from the coronary vessel to the heart chamber during diastole.
Claim 13
Dependent Claim 23 words
The system of claim 10 , wherein the natural valve includes a section of blood vessel containing at least one naturally occurring valve.
Claim 14
Dependent Claim 18 words
The system of claim 11 , wherein the section of blood vessel lines an interior of the tube.
Claim 15
Dependent Claim 16 words
The system of claim 11 , wherein the section of blood vessel is a human vein.
Claim 16
Dependent Claim 15 words
The system of claim 11 , wherein the section of blood vessel is an autograft.
Claim 17
Dependent Claim 15 words
The system of claim 11 , wherein the section of blood vessel is an allograft.
Claim 18
Dependent Claim 15 words
The system of claim 11 , wherein the section of blood vessel is a xenograft.
Claim 19
Dependent Claim 15 words
The system of claim 10 , wherein the natural valve is disposed inside the tube.
Claim 20
Dependent Claim 14 words
The system of claim 10 , wherein the heart chamber is a left ventricle.
Claim 21
Dependent Claim 14 words
The system of claim 10 , wherein the coronary vessel is a coronary artery.

References Cited (Backward Citations)

US4118806A Cited
US4441215A Cited
US4546499A Cited
US4562597A Cited
US4733665A Cited
US4733665C2 Cited
US4733665B1 Cited
US4769029A Cited
US5527337A Cited
US5824038A Cited
US6004261A Cited
US4953553A Cited
US5500014A Cited
US5609626A Cited
US5997573A Cited
US5275580A Cited
US5147388A Cited
US5344426A Cited
US5840081A Cited
US5411552A Cited
US6168614B1 Cited
US5389096A Cited
US5193546A Cited
US5456712A Cited
US5979455A Cited
US5571167A Cited
US5545214A Cited
US5554119A Cited
US5593434A Cited
US5470320A Cited
US5758663A Cited
US5332402A Cited
US5258008A Cited
US5330486A Cited
US5287861A Cited
US5429144A Cited
US5409019A Cited
US5571215A Cited
US20040019348A1 Cited
US6197296B1 Cited
US6004347A Cited
US5618299A Cited
US5976650A Cited
US5935161A Cited
US6001123A Cited
US5993481A Cited
US6004348A Cited
EP0732088B1 Cited
US5733267A Cited
WO1996032972A1 Cited
US20030044315A1 Cited
US6458323B1 Cited
US6322548B1 Cited
WO1996035469A1 Cited
US5997525A Cited
WO1996039962A1 Cited
US5976192A Cited
WO1996039964A1 Cited
WO1996039965A1 Cited
US6132451A Cited
US5797946A Cited
US6156031A Cited
US5830222A Cited
US6159225A Cited
WO1997013463A1 Cited
US20010047165A1 Cited
US6283983B1 Cited
WO1997013471A1 Cited
US20030236542A1 Cited
EP1166721A3 Cited
US6068638A Cited
US6375615B1 Cited
US6231587B1 Cited
US6190353B1 Cited
US5865723A Cited
US5885259A Cited
US6033582A Cited
WO1997027893A1 Cited
WO1997027898A1 Cited
WO1997027897A1 Cited
EP0792624B1 Cited
US5878751A Cited
US5810836A Cited
US6080163A Cited
WO1997032551A1 Cited
US6669709B1 Cited
EP0797957A1 Cited
EP0797958A1 Cited
EP0801928B1 Cited
EP0799604A1 Cited
WO1997043961A1 Cited
US5662124A Cited
US5908028A Cited
US6363939B1 Cited
US20020092535A1 Cited
EP0815798A3 Cited
WO1998003118A1 Cited
US6569147B1 Cited
US6524323B1 Cited
US6080170A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 2008-04-18 2008-10-18 2009-04-19 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 2012-04-18 2012-10-18 2013-04-19 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 2016-04-18 2016-10-18 2017-04-19 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag